soul trial oral semaglutide cardiovascular outcomes results 2025 2024 nejm 💥Soul study group recently shared SELECT: Semaglutide's Impact on CVD

Semaglutide and tirzepatide have demonstrated weight reductions of 10 to 20 percent in many patients

The Trellis vs

Supports the phases of detoxification and toxin removal from the body

Don't wait for future approvals to start prioritizing your metabolic health

The type III ANOVA analysis via Satterthwaites degrees of freedom was performed using the R package lmerTest [47] to assess the significance of the main effects, whereas significant relationships were further explored via estimated marginal means analysis using the package emmeans V1.11.1 [48], thus, a Tukey-adjusted contrasts pair wise comparison was also carried out

Diabetes, Obesity, and Metabolism, 25 (4), 975-984